Packaging & Labelling
Articles
Examining the operational challenges presented by serialisation
The deadlines for serialisation compliance in the EU and the U.S. are drawing closer. For many pharmaceutical companies, the journey towards implementing a full serialisation solution is well underway, but for others the complexity of the task means that...
Packaging & Labelling
Bosch launches a pilot fermenter for manufacturing APIs
Bosch has launched a new pilot fermenter for the cultivation of active pharmaceutical ingredients (APIs) on laboratory and pilot scale. โIn theย pharmaceutical industry, the manufacture of complex compounds using biotechnological methods continues to grow in importance. ...
Packaging & Labelling
Research reveals manufacturers and contract packagers may miss serialization deadlines
New industry research reveals that more than one third (36 per cent) of pharmaceutical manufacturers and contract packagers are not currently preparing for global serialization requirements, despite impending deadlines.ย The research, conducted by serialization system provider...
Packaging & Labelling
Bosch Packaging Technology presents line and systemsย competence in the age of digitization
Bosch Packaging Technology generated sales ofย 1.3 billion euros in the 2016 fiscal year, similar to the previous year.As in years past, the leading provider of process and packaging technology,ย headquartered in Waiblingen near Stuttgart, Germany, split its sales more or...
Packaging & Labelling
Bosch presents connected solutions for higher process and product safety at interpack 2017
At interpack 2017, Bosch Packaging Technology showsย how Industry 4.0 solutions help to achieve higher process safety and product quality. โEspecially in the pharmaceutical and food industries, both manufacturers and endย consumers expect absolutely safe products,โ says Dr...
Articles
The Arrival of Quality by Design in Logistics
Quality by Design (QbD) is a concept that has become mainstream in the pharmaceutical manufacturing space in recent years.
QbD is a science- and risk-based approach to quality that identities, measures and defines the critical processes that impact quality and...
Articles
Overcoming the Challenges and Complexities of the Personalized Medicine Supply Chain
The last decade has seen an increased emphasis on research andย development into personalized medicines, including cell, geneย and immunotherapy treatments
A trend that is expected to continueย due to the forecasted 8.74% CAGR of the personalized medicine,targeted therapeutics, and companion diagnostics market...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















